Cargando…
Interaction of hematopoietic CD34(+) CD45(+) stem cells and cancer cells stimulated by TGF-β1 in a model of glioblastoma in vitro
The majority of modern treatment methods for malignant brain tumors are not sufficiently effective, with a median survival time varying between 9 and 14 months. Metastatic and invasive processes are the principal characteristics of malignant tumors. The most important pathogenic mechanism is epithel...
Autores principales: | Milkina, Elena, Ponomarenko, Arina, Korneyko, Maria, Lyakhova, Irina, Zayats, Yulia, Zaitsev, Sergey, Mischenko, Polina, Eliseikina, Marina, Khotimchenko, Yuri, Shevchenko, Valeryi, Sharma, Hari, Bryukhovetskiy, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151884/ https://www.ncbi.nlm.nih.gov/pubmed/30226551 http://dx.doi.org/10.3892/or.2018.6671 |
Ejemplares similares
-
Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review)
por: Bryukhovetskiy, Igor, et al.
Publicado: (2018) -
Alkaloids of fascaplysin are effective conventional chemotherapeutic drugs, inhibiting the proliferation of C6 glioma cells and causing their death in vitro
por: Bryukhovetskiy, Igor, et al.
Publicado: (2017) -
Hematopoietic stem cells as a tool for the treatment of glioblastoma multiforme
por: Bryukhovetskiy, Igor S., et al.
Publicado: (2016) -
Cancer stem cells and microglia in the processes of glioblastoma multiforme invasive growth
por: Bryukhovetskiy, Igor, et al.
Publicado: (2016) -
Directional migration of adult hematopoeitic progenitors to C6 glioma in vitro
por: BRYUKHOVETSKIY, IGOR STEPANOVICH, et al.
Publicado: (2015)